Babies get the hepatitis B vaccine at birth because their immune systems are uniquely vulnerable to the virus. When an infant contracts hepatitis B, there’s up to a 90% chance it becomes a lifelong chronic infection. For older children and adults who catch the same virus, that risk drops to just 5% to 10%. This massive difference in outcomes is the core reason vaccination starts within the first 24 hours of life.
Why Infants Face Greater Danger
Hepatitis B is a virus that attacks the liver. In most healthy adults, the immune system fights it off within a few months, and the infection clears permanently. A baby’s immune system doesn’t mount the same fight. Instead, the virus quietly establishes itself in the liver and stays there, often for life.
Chronic hepatitis B is not a mild condition. People living with it face a significantly higher risk of liver cirrhosis (scarring that permanently damages the liver) and liver cancer. Roughly one in four infants who develop chronic infection will eventually die from chronic liver disease. These consequences can take decades to appear, which is part of what makes infant infection so dangerous: a baby infected at birth may not show symptoms for 20 or 30 years, by which point serious liver damage has already occurred.
How Babies Get Exposed
The most direct route is during birth. A mother carrying hepatitis B can pass it to her baby during delivery, and many carriers don’t know they’re infected. Hepatitis B often causes no symptoms at all, so a pregnant person can test negative on a screening they never received or have an infection that was simply never detected. Without vaccination and immune globulin given shortly after birth, about 90% of babies born to infected mothers will develop chronic infection.
But mother-to-child transmission isn’t the only risk. Hepatitis B spreads through blood and body fluids, and within households, close daily contact creates opportunities. Sharing towels, exposure to small cuts or skin conditions, and even sharing chewed food between siblings or caregivers can transmit the virus. In families where a father, grandparent, or older sibling carries hepatitis B, transmission to young children is well documented. The virus is also remarkably hardy: it can survive on surfaces outside the body for at least seven days, remaining infectious the entire time.
This is why every infant receives the vaccine regardless of the mother’s test results. Relying solely on prenatal screening misses too many cases. The birth dose acts as a safety net that protects babies from both known and unknown exposures.
What the Vaccine Schedule Looks Like
The hepatitis B series requires three doses. The first is given within 24 hours of birth. The second typically comes at one month of age, and the third between 6 and 18 months, depending on which vaccine your pediatrician uses. Some combination vaccines that also protect against other diseases (like diphtheria, tetanus, whooping cough, and polio) can be used for the later doses starting at six weeks of age.
Completing all three doses is important. The full series provides long-term protection against both acute and chronic hepatitis B infection, and most healthy people never need a booster dose afterward. That means three shots in infancy can provide protection that lasts well into adulthood and potentially for life.
How Effective the Vaccine Has Been
Countries that introduced universal infant vaccination have seen dramatic results. A large systematic review published in the Bulletin of the World Health Organization found that populations offered universal infant vaccination had a 76% lower prevalence of hepatitis B infection compared to unvaccinated populations. In Taiwan and China, where hepatitis B was historically very common and vaccination programs started early, the reduction reached 83%.
These aren’t small, incremental gains. Entire generations of children have grown up protected from a virus that previously caused widespread chronic liver disease. Before routine vaccination began in the United States in 1991, an estimated 18,000 children were infected with hepatitis B each year. The vaccine has nearly eliminated new childhood infections in countries with high coverage rates.
Safety in Newborns
The hepatitis B vaccine has been used in newborns since 1986, giving it one of the longest safety track records of any pediatric vaccine. It contains no live virus. The vaccine works by introducing a small, lab-made protein from the surface of the hepatitis B virus, which teaches the immune system to recognize and fight the real virus if exposed later.
The most common side effects in infants are mild: irritability, drowsiness, temporary loss of appetite, or fussiness. A large study comparing vaccinated and unvaccinated newborns found no difference in death rates between the two groups. Separate CDC research found no increase in fevers, allergic reactions, or neurological problems after newborn vaccination. The largest case series review of hepatitis B vaccine reports among newborns and infants identified no serious health problems linked to the vaccine.
Why Not Wait Until the Child Is Older
This is the question many parents naturally ask. If hepatitis B spreads through blood and body fluids, why not wait until a child is older and more likely to encounter those risks? The answer comes back to that 90% number. The younger a child is when infected, the more likely the infection becomes permanent. Waiting even a few months creates a window where an unprotected baby could be exposed through household contact, a caregiver they interact with, or a medical situation no one anticipated.
Prenatal screening catches many infected mothers, but no screening program is perfect. Lab errors happen, infections acquired late in pregnancy can be missed, and some births occur without adequate prenatal care. The birth dose eliminates the need to rely on a flawless chain of testing and reporting. It simply protects every baby from day one, regardless of circumstances.
There’s also a practical benefit to starting at birth: babies who receive their first dose in the hospital are more likely to complete the full three-dose series. Delaying the start makes it easier for doses to be missed during the busy early months of parenthood, leaving the child partially or fully unprotected.